FRA:ACT - DE000A2YNT30 - Common Stock
The current stock price of ACT.DE is 143.6 EUR. In the past month the price decreased by -7.27%. In the past year, price increased by 228.81%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
GIN.DE | GIVAUDAN-REG | 28.24 | 34.91B | ||
SIKA.DE | SIKA AG-REG | 24.35 | 31.93B | ||
6D81.DE | DUPONT DE NEMOURS INC | 17.25 | 27.45B | ||
DSFIR.AS | DSM-FIRMENICH AG | 87.17 | 21.77B | ||
BRG.OL | BORREGAARD ASA | 23.48 | 20.85B | ||
ELK.OL | ELKEM ASA | N/A | 16.01B | ||
SY1.DE | SYMRISE AG | 22.83 | 11.58B | ||
AKZA.AS | AKZO NOBEL N.V. | 16.28 | 10.50B | ||
1COV.DE | COVESTRO AG | N/A | 10.45B | ||
SYENS.BR | SYENSQO SA | 20.05 | 7.77B | ||
EVK.DE | EVONIK INDUSTRIES AG | 9.83 | 7.65B | ||
AMC.DE | ALBEMARLE CORP | N/A | 7.22B |
Alzchem Group AG engages in the provision of development, production, and marketing of chemical products. The company is headquartered in Trostberg, Bayern and currently employs 1,725 full-time employees. The Group's operating business is divided into three segments: Specialty Chemicals, Basics & Intermediates and Other & Holding. Its products can be applied in areas, such as nutrition, renewable energy, fine chemicals, agriculture and metallurgy. The firm produces dietary supplements; epoxy resin hardeners for use in adhesives, powder coatings, printed circuit boards and composites; silicon nitride for advanced ceramics and solar wafers; technical gases; specialty fertilizer, germicide for use in pig pens, plant growth regulators and plant protection additives, among others. The company also provides related services. The firm operates production sites in Germany and Sweden, a sales subsidiary in the United States and a Chinese subsidiary for the purchase of raw materials and distribution in Asia.
ALZCHEM GROUP AG
Chemiepark Trostberg, Dr. Albert-Frank-Str. 32
Trostberg BAYERN DE
Employees: 1725
Phone: 498621860
The current stock price of ACT.DE is 143.6 EUR. The price increased by 2.28% in the last trading session.
The exchange symbol of ALZCHEM GROUP AG is ACT and it is listed on the Deutsche Boerse Ag exchange.
ACT.DE stock is listed on the Deutsche Boerse Ag exchange.
11 analysts have analysed ACT.DE and the average price target is 143.84 EUR. This implies a price increase of 0.17% is expected in the next year compared to the current price of 143.6. Check the ALZCHEM GROUP AG stock analysts ratings, price target forecast and up-and down grades for more detailed information.
ALZCHEM GROUP AG (ACT.DE) has a market capitalization of 1.46B EUR. This makes ACT.DE a Small Cap stock.
ALZCHEM GROUP AG (ACT.DE) currently has 1725 employees.
ALZCHEM GROUP AG (ACT.DE) has a support level at 136.99 and a resistance level at 140.94. Check the full technical report for a detailed analysis of ACT.DE support and resistance levels.
The Revenue of ALZCHEM GROUP AG (ACT.DE) is expected to grow by 2.96% in the next year. Check the estimates tab for more information on the ACT.DE EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ALZCHEM GROUP AG (ACT.DE) has a dividend yield of 1.29%. The yearly dividend amount is currently 1.2. Check the full fundamental report for a detailed analysis of ACT.DE dividend history, reliability and sustainability.
ALZCHEM GROUP AG (ACT.DE) will report earnings on 2025-10-30.
The PE ratio for ALZCHEM GROUP AG (ACT.DE) is 25.15. This is based on the reported non-GAAP earnings per share of 5.71 and the current share price of 143.6 EUR. Check the full fundamental report for a full analysis of the valuation metrics for ACT.DE.
ChartMill assigns a technical rating of 7 / 10 to ACT.DE. When comparing the yearly performance of all stocks, ACT.DE is one of the better performing stocks in the market, outperforming 99.07% of all stocks.
ChartMill assigns a fundamental rating of 7 / 10 to ACT.DE. Both the health and profitability get an excellent rating, making ACT.DE a very profitable company, without any liquidiy or solvency issues.
Over the last trailing twelve months ACT.DE reported a non-GAAP Earnings per Share(EPS) of 5.71. The EPS increased by 25.65% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 10.43% | ||
ROA | 10.48% | ||
ROE | 26.66% | ||
Debt/Equity | 0.18 |
11 analysts have analysed ACT.DE and the average price target is 143.84 EUR. This implies a price increase of 0.17% is expected in the next year compared to the current price of 143.6.
For the next year, analysts expect an EPS growth of 16.75% and a revenue growth 2.96% for ACT.DE